ライフサイエンスコーパス: total body irradiation

1 sted of fludarabine (90 mg/m2) and 2 to 3 Gy total body irradiation.

2 e transplanted after varying doses of cGy of total body irradiation.

3 tion of IL-22 enhanced thymic recovery after total body irradiation.

4 ipheral blood compartments of mice post-4 Gy total body irradiation.

5 VCA recipients with 200-, 300-, and 400-cGy total body irradiation.

6 yclophosphamide, fludarabine, and 200 cGy of total body irradiation.

7 test abnormalities among those who received total body irradiation.

8 ell receptor monoclonal antibody followed by total body irradiation.

9 20 lymphoma in mice preconditioned with 6 Gy total body irradiation.

10 -identical marrow transplantation after 1 Gy total body irradiation.

11 with (131)I-BC8 Ab and fludarabine plus 2 Gy total body irradiation.

12 exhibit enhanced survival following 8-10 Gy total body irradiation.

13 ltered urine from cancer patients undergoing total body irradiation.

14 and responded to antigenic stimulation after total body irradiation.

15 tical donors after conditioning with 920 cGy total body irradiation.

16 ation therapy in mice with anemia induced by total body irradiation.

17 ative conditioning with fludarabine and 2 Gy total body irradiation.

18 e marrow after conditioning with 100-300 cGy total body irradiation.

19 these biomarker genes in patients undergoing total body irradiation.

20 conditioning, primarily cyclophosphamide and total body irradiation.

21 e given HSCT after conditioning with 920 cGy total body irradiation.

22 s were conditioned with cyclophosphamide and total body irradiation.

23 and hematopoietic radioprotection following total body irradiation.

24 ft and a conditioning regimen with > 450 cGy total body irradiation.

25 autologous bone marrow transplantation after total body irradiation.

26 depletion-based conditioning with 1 or 3 Gy total body irradiation.

27 increases survival of mice exposed to lethal total body irradiation.

28 occurred within the IFRT site and five after total-body irradiation.

29 ustained engraftment can be achieved without total-body irradiation.

30 Conditioning therapy involved total body irradiation 2 Gy +/- fludarabine 30 mg/m2.

31 oablative conditioning regimen consisting of total-body irradiation (2 Gy) with or without fludarabin

32 RIC regimens included fludarabine/total body irradiation 200 cGy (n = 5) or 450 cGy (n = 1

33 phamide (50 mg/kg), and a single fraction of total body irradiation (200 cGy) with cyclosporine and m

34 underwent conditioning with a single dose of total-body irradiation (200 cGy).

35 g of alemtuzumab (1 mg/kg in divided doses), total-body irradiation (300 cGy), sirolimus, and infusio

36 Eight recipient dogs received total body irradiation (4.5 cGy), hematopoietic cell tra

37 hosphamide 14.5 mg/kg on days -6 and -5, and total body irradiation 400 cGy administered as a single

38 D154/rapamycin plus 100, 200, and 300 cGy of total body irradiation, 42.9%, 85.7%, and 100% of mice e

39 5% CI 2.3-7.7), ifosfamide (24.9, 7.4-83.5), total body irradiation (6.9, 2.3-21.1), and mean kidney

40 HDIT included total body irradiation (800 cGy) with lung shielding, cy

41 We found that total body irradiation, a conditioning regimen required

42 ere hypoplastic and more apoptotic 24 h post-total body irradiation, a time when stem cell survival i

43 men involving anti-CD154 and low dose (3 Gy) total body irradiation, allowing achievement of mixed ch

44 = 498) or unrelated (n = 336) HCT after 2 Gy total body irradiation alone (n = 171) or combined with

45 nstitutions using conditioning with low-dose total body irradiation alone or combined with fludarabin

46 ated donors following conditioning with 2 Gy total body irradiation alone or in combination with flud

47 ne-refractory CLL were conditioned with 2 Gy total-body irradiation alone or combined with fludarabin

48 Our results show that total body irradiation alters intracellular signaling an

49 oietic cells using a combination of low-dose total body irradiation and a short course of immunosuppr

50 n (BMT) following conditioning with low-dose total body irradiation and anti-CD154 antibody.

51 rance are achieved in mice receiving 3 Gy of total body irradiation and anti-CD154 mAb followed by al

52 ents received a single fraction dose of 2 Gy total body irradiation and HC transplants from HLA-ident

53 ient Tregs after a conditioning regimen with total body irradiation and led to a TGF-beta-dependent i

54 -ibritumomab tiuxetan, fludarabine, and 2 Gy total body irradiation and matched-related (15) or unrel

55 of pretransplant T cell depletion, low-dose total body irradiation and posttransplant (donor) bone m

56 Total body irradiation and radiation proctitis were moni

57 r nonmyeloablative (3 Gy) and minimal (1 Gy) total body irradiation and treatment with costimulation

58 clophosphamide (CY) and busulfan (BU) (67%), total-body irradiation and CY (21%), BU-fludarabine (10%

59 The conditioning regimen included total-body irradiation and cyclophosphamide (n = 3), bus

60 preconditioning or after 200 cGy or 900 cGy total-body irradiation and evaluated after 4 months.

61 etic stem-cell transplantation that includes total-body irradiation and treatment with alemtuzumab an

62 smoking history, conditioning with high-dose total body irradiation, and an absolute lymphocyte count

63 globulin, fludarabine, cyclophosphamide, and total body irradiation, and graft-versus-host disease pr

64 nsolidation with myeloablative chemotherapy, total-body irradiation, and ABMT versus three cycles of

65 NOD mice received various combinations of total body irradiation, anti-CD154, anti-CD8alpha, anti-

66 recipients who receive conditioning without total body irradiation are not well known.

67 al cell apoptosis after they were exposed to total body irradiation as compared with TNFR1-deficient

68 13)Bi)-labeled anti-CD45 antibody to replace total body irradiation as conditioning for hematopoietic

69 The use of total body irradiation as part of conditioning regimens

70 re enriched early after TLI/ATS + BMT versus total body irradiation/ATS + BMT.

71 X compared with TLI/ATS, lethal or sublethal total body irradiation/ATS/CTX, or CTX/ATS conditioning.

72 s the antileukemic benefits of myeloablative total body irradiation-based conditioning and unrelated

73 cantly higher rate of DC was associated with total body irradiation-based conditioning and with acute

74 critical to the induction of tolerance in a total body irradiation-based model.

75 sed with hematologic malignancies received a total body irradiation-based myeloablative conditioning

76 te deletional tolerance as the mechanism for total body irradiation-based nonmyeloablative conditioni

77 in patients conditioned with a fractionated total body irradiation-based regimen has shown encouragi

78 blastic leukemia 10) were conditioned with a total body irradiation-based regimen.

79 hocytic leukemia patients treated with 12 Gy total body irradiation-based regimens and allogeneic tra

80 ted donor transplantation with myeloablative total body irradiation-based regimens.

81 lymphoma who were considered ineligible for total-body irradiation because of older age or prior rad

82 shed in dogs given a sublethal dose (1-2 Gy) total body irradiation before and a short course of immu

83 ditioning of neonates with 100 to 400 cGy of total body irradiation before normal donor marrow transp

84 mg/kg, fludarabine 200 mg/m2, and 200 cGy of total body irradiation (Bu/Flu/TBI).

85 tumoral proliferation of T-effector cells in total body irradiation-conditioned recipients.

86 The toxicity of total body irradiation conditioning and potential for gr

87 e marrow (BM) cells or through myeloablative total body irradiation conditioning and reconstitution w

88 Furthermore, this procedure usually requires total body irradiation conditioning of recipients.

89 day pulmonary metastases of MCA 205 received total body irradiation conditioning or were nonirradiate

90 However, when mice were given more intense total body irradiation conditioning regimens combined wi

91 To reduce or eliminate total body irradiation conditioning regimens, we have so

92 ex vivo antigen stimulation irrespective of total body irradiation conditioning.

93 CD34+ cells can engraft even after low-dose total body irradiation conditioning.

94 Total body irradiation-containing preparative regimen wa

95 When used with cyclophosphamide/total body irradiation (Cy/TBI) conditioning, sirolimus

96 Cyclophosphamide combined with total body irradiation (Cy/TBI) or busulfan (BuCy) are t

97 nditioning regimens of cyclophosphamide plus total body irradiation (CY/TBI), busulfan plus cyclophos

98 ioned with cyclophosphamide and fractionated total-body irradiation (Cy/TBI) or busulfan and cyclopho

99 ransplantation conditioning regimen (2 Gy of total-body irradiation, cyclophosphamide, and fludarabin

100 receptor and anti-CD8 monoclonal antibodies, total body irradiation, cyclosporine A and mycophenolate

101 Although the addition of 600 rad of total body irradiation delayed tumor growth, further ado

102 ll transplantation with cyclophosphamide and total body irradiation develop wide-spectrum manifestati

103 erance, significantly decreasing the minimum total body irradiation dose required.

104 The omission of high-dose total body irradiation, dose adjustments of busulfan to

105 ent regimens:fludarabine-melphalan (n = 46); total body irradiation-etoposide (n = 28), and busulfan-

106 Rabbits exposed to 10 cGy of total body irradiation exhibited T cell deficiency, with

107 eparative regimen of nonmyeloablating (5 Gy) total body irradiation experienced the rapid rejection o

108 ancies conditioned with fludarabine and 2 Gy total body irradiation followed by HLA-matched unrelated

109 in which the marrow recipients received 2 Gy total body irradiation followed by marrow infusions from

110 ated with a nonmyeloablative dose of 200 cGy total body irradiation followed by matched-littermate SC

111 of a specific anti-CD44 mAb (S5) and 200 cGy total body irradiation followed by postgrafting immunosu

112 Total body irradiation followed by transplantation with

113 d MCA-205 tumors were treated with sublethal total body irradiation, followed by adoptive transfer of

114 were uniformly cured after administration of total body irradiation, followed by the transplantation

115 e were conditioned with 1000 cGy single dose total body irradiation, followed by transplantation of 1

116 (P=0.01) and, in multivariate analysis, with total body irradiation for all lineages (P<0.01).

117 ne tumor recipients were preconditioned with total body irradiation from 0 to 500 cGy or with a 30-da

118 is study, we investigated whether increasing total body irradiation from 200 cGy to 400 cGy would imp

119 matched sibling donors received fractionated total body irradiation (FTBI) and high-dose VP16, wherea

120 n consisted of 90 mg/m2 fludarabine and 2 Gy total body irradiation given before and mycophenolate mo

121 ludarabine and targeted busulfan (n = 25) or total body irradiation (>/=12 Gy; n = 18).

122 nner, with the administration of DA prior to total body irradiation having the greatest protective ef

123 ctive regimen consisted of hyperfractionated total body irradiation (HFTBI), thiotepa, and fludarabin

124 T was seen only in patients conditioned with total-body irradiation (HR, 3.9 [95% CI, 2.6-6.8]).

125 losuppressive regimen, consisting of 100 cGy total body irradiation, immunotoxin mediated T-cell depl

126 ry of young BM ECs along with HSCs following total body irradiation improved HSC engraftment and enha

127 esus macaques conditioned with myeloablative total body irradiation in the absence or presence of sin

128 Conditioning included total-body irradiation in 92% of patients.

129 unotherapy targeting CD45 may substitute for total-body irradiation in hematopoietic cell transplanta

130 ive preparative regimen that did not involve total-body irradiation in young children with Hurler's s

131 In contrast, no significant increase in total body irradiation-induced apoptosis or tissue injur

132 iation-induced gastrointestinal syndrome and total body irradiation-induced hematopoietic failure.

133 show that p50-/- mice are more sensitive to total body irradiation-induced lethality than wild-type

134 examined the role of NFkappaB activation in total body irradiation-induced tissue damage.

135 Exposure of mice to total body irradiation induces nuclear factor kappaB (NF

136 g from the combined effects of cyclosporine, total body irradiation, infections, high-dose chemothera

137 reert2)/Met(+/+)/LacZ) were exposed to 10 Gy total body irradiation; intestinal tissues were collecte

138 Total body irradiation is a component in various host co

139 hematopoietic regeneration in vivo following total body irradiation is dependent upon EGFR-mediated r

140 experimental and clinical scenarios in which total body irradiation is involved.

141 approach requires conditioning regimens with total body irradiation, lymphodepleting chemotherapy, an

142 NFkappaB activated by total body irradiation mainly consists of NFkappaB p50/R

143 Upon total body irradiation, medullary complexity was partial

144 D154 (MR1) and rapamycin (Rapa) plus 100 cGy total body irradiation (MR1/Rapa/100 cGy) and transplant

145 were conditioned with cyclophosphamide with total body irradiation (n = 39) or busulfan (n = 1).

146 4, 3, and 2 days before receiving 2 or 3 Gy total body irradiation on the day of HSCT (day 0).

147 simulated weightlessness and space-relevant total-body irradiation on vascular responsiveness in mic

148 mice were lymphodepleted by nonmyeloablative total body irradiation or a myeloablative regimen that r

149 e latter treatment, however, did not require total body irradiation or adoptive cell transfer and res

150 there was no difference between receiving a total body irradiation or busulfan based regimens (P = .

151 yclophosphamide associated with fractionated total body irradiation or busulfan.

152 myeloablative regimens, ie, those including total body irradiation or high-dose busulfan.

153 l HCT, where recipients are conditioned with total body irradiation or high-dose chemotherapy.

154 philia A BALB/c mice after reduced-intensity total body irradiation or nonmyeloablative chemotherapy

155 t differences in hazards were observed after total-body irradiation or receipt of an allogeneic versu

156 male sexual function domains declined after total body irradiation (P < .05).

157 m(2) x 5, cyclophosphamide 50 mg/kg, 200 cGy total body irradiation), patients received either matche

158 Patients treated with C-HDT received total body irradiation plus chemotherapy (70%) or chemot

159 h busulfan plus cyclophosphamide and 12 with total body irradiation plus chemotherapy.

160 The patients received 300 cGy of total-body irradiation plus alemtuzumab before transplan

161 iation of conditioning therapy (fractionated total-body irradiation plus high-dose chemotherapy) and

162 sk for osteoporosis and bone fractures after total body irradiation preconditioning.

163 Although nonmyeloblative total body irradiation prevented organ graft rejection,

164 depletion with CD3-immunotoxin, and 100 cGy total body irradiation prior to hematopoietic cell trans

165 A single injection of CBLB502 before lethal total-body irradiation protected mice from both gastroin

166 Univariate analysis showed that fractionated total body irradiation, race, and use of cytarabine sign

167 However total-body irradiation, radiation to the gonads, and che

168 Total body irradiation reduced numbers of proliferating

169 r without T-cell lymphodepletion reduced the total body irradiation requirement to 100 cGy for establ

170 Total body irradiation (RR = 0.6) provided a protective

171 Mice subjected to total body irradiation showed alterations in glucose met

172 or-bearing mice with DMA 2 hours before 8 Gy total body irradiation showed an impressive rescue of ra

173 nti-FVIII immune response, and together with total body irradiation, suppresses anti-FVIII immune res

174 serum at 10 mg at day +10 (single dose), and total-body irradiation t 300 cGy (day 0) before bone-mar

175 s 11.0%, higher among survivors who received total body irradiation (TBI) (17%) than those who did no

176 ence indicates that the addition of low-dose total body irradiation (TBI) (2-4 Gy) to reduced intensi

177 ed: (1) myeloablative conditioning (MA) with total body irradiation (TBI) + PBSCs, (2) MA + TBI + BM,

178 that antithymocyte globulin (ATG) given with total body irradiation (TBI) 200 cGy and fludarabine res

179 re we use bone marrow transplantation (BMT), total body irradiation (TBI) and abdominal irradiation (

180 Lymphodepletion using total body irradiation (TBI) and administering high-dose

181 littermate recipients consisting of 450 cGy total body irradiation (TBI) and anti-CD44 monoclonal an

182 man urine data sets from patients undergoing total body irradiation (TBI) and from a colorectal cance

183 mone (GH) deficiency are complications after total body irradiation (TBI) and hematopoietic cell tran

184 ce were conditioned with decreasing doses of total body irradiation (TBI) and reconstituted with bone

185 ) cell recovery in rhesus macaques following total body irradiation (TBI) and reinfusion of vector-tr

186 BALB/c mice were treated with total body irradiation (TBI) and then infused with C57Bl

187 onmyeloablative chemotherapy with or without total body irradiation (TBI) before adoptive T-cell tran

188 Total body irradiation (TBI) before allogeneic hematopoi

189 anti-CD45 radioimmunotherapy (RIT) replacing total body irradiation (TBI) before haploidentical HCT i

190 Four dogs received 920 cGy total body irradiation (TBI) before infusion of autologo

191 Total body irradiation (TBI) can induce lethal myelosupp

192 lantation (BMT), but this procedure requires total body irradiation (TBI) conditioning of the recipie

193 engraftment was only transient with 100 cGy total body irradiation (TBI) conditioning, indicating su

194 at under myeloablative and reduced-intensity total body irradiation (TBI) conditioning, transplantati

195 Total body irradiation (TBI) damages hematopoietic cells

196 We examined the impact of total body irradiation (TBI) dose and fractionation on r

197 eic transplantation with regimens of varying total body irradiation (TBI) doses (0-1575 cGy), with an

198 Total body irradiation (TBI) exposure was associated wit

199 equires the recipient mice to undergo lethal total body irradiation (TBI) followed by rescue with who

200 BMT, rats were treated with varying doses of total body irradiation (TBI) followed by transplantation

201 not been compared with cyclophosphamide plus total body irradiation (TBI) in adults with advanced ref

202 emission at the time of allo-HSCT and use of total body irradiation (TBI) in patients with non-Hodgki

203 rs of 2 articles have compared busulfan with total body irradiation (TBI) in preparative regimens for

204 Lymphodepletion with total body irradiation (TBI) increases the efficacy of a

205 ood, Shao et al report that a side effect of total body irradiation (TBI) is long-term bone marrow in

206 Fractionated, high-dose total body irradiation (TBI) is used therapeutically to

207 myeloablative conditioning regimens--200 cGy total body irradiation (TBI) or 10 mg/kg busulfan--with

208 (BMT) after conditioning with either lethal total body irradiation (TBI) or an established nonmyeloa

209 in the bone marrow (BM) as a consequence of total body irradiation (TBI) or granulocyte colony-stimu

210 Mice were subjected to either total body irradiation (TBI) or partial body irradiation

211 s studies showed that treatment of mice with total body irradiation (TBI) or total lymphoid tissue ir

212 monoclonal antibody before conditioning with total body irradiation (TBI) prevents GVHD but retains G

213 nonmyeloablative chemotherapeutic agents or total body irradiation (TBI) prior to adoptive transfer

214 inhibition using AZ31 prior to 9 or 9.25 Gy total body irradiation (TBI) reduced median time to mori

215 treatment, we determined the minimal dose of total body irradiation (TBI) required when added to anti

216 C57BL/6 mice to a sublethal dose (6.5 Gy) of total body irradiation (TBI) resulted in a sustained qua

217 requency of side effects caused by high-dose total body irradiation (TBI) the nonmyeloablative regime

218 Addition and intensification of total body irradiation (TBI) to the preparative lymphode

219 Lethal total body irradiation (TBI) triggers multifactorial hea

220 ) given conventional conditioning, high-dose total body irradiation (TBI) was associated with an incr

221 Total body irradiation (TBI) was associated with develop

222 ft rejection after conditioning with 1 Gy of total body irradiation (TBI) was consistently seen in hi

223 e NSG host environment using preconditioning total body irradiation (TBI) was indispensable for effic

224 ynomolgus monkeys, cyclophosphamide (CP) and total body irradiation (TBI) were compared as part of a

225 l HSCT in which 27 patients conditioned with total body irradiation (TBI) were given a fixed dose of

226 single-exposure, high dose rate (30 cGy/min) total body irradiation (TBI) with cyclophosphamide as co

227 6 transplantation model and ascertained that total body irradiation (TBI) with establishment of chime

228 yeloablative conditioning consisting of 2 Gy total body irradiation (TBI) with or without added fluda

229 of fludarabine, anti-thymocyte globulin, and total body irradiation (TBI) would enable reduction of t

230 itioned with CD45-SAP, CD45-SAP plus 2 Gy of total body irradiation (TBI), 2 Gy of TBI, 8 Gy of TBI,

231 al antibodies (mAbs) on Days -6 and -1, 3 Gy total body irradiation (TBI), and 7 Gy thymic irradiatio

232 eived cyclophosphamide (CY), single fraction total body irradiation (TBI), and antithymocyte globulin

233 re treated with cyclophosphamide, etoposide, total body irradiation (TBI), and PBSCT.

234 unrelated donors were rejected after 9.2 Gy total body irradiation (TBI), and that graft resistance

235 ty conditioning (RIC) consisting of low-dose total body irradiation (TBI), cyclophosphamide, and flud

236 is upregulated during lymphopenia induced by total body irradiation (TBI), cyclophosphamide, or Thy1

237 f the endosteal osteoblastic HSC niche after total body irradiation (TBI), defined as relocalization

238 Nonmyeloablative regimens were 2 Gy total body irradiation (TBI), either alone (n = 40) or c

239 ril, an ACE inhibitor, initiated 1-4 h after total body irradiation (TBI), improved Hematopoietic Acu

240 ransplantation regimen consisted of low-dose total body irradiation (TBI), preceded in some patients

241 animals were submitted at 60 days to 9.5-Gy total body irradiation (TBI), reconstituted immediately

242 ests that intense immune suppression using a total body irradiation (TBI)-based regimen and hematopoi

243 ive intravenous busulfan (IV-BU) vs ablative total body irradiation (TBI)-based regimens in myeloid m

244 outcome when patients had undergone previous total body irradiation (TBI)-containing myeloablative tr

245 second relapse was significantly lower after total body irradiation (TBI)-containing transplant regim

246 way as a new mechanism for the mitigation of total body irradiation (TBI)-induced mortality.

247 recovery in the blood and bone marrow after total body irradiation (TBI).

248 cy, we developed a murine model of sublethal total body irradiation (TBI).

249 isease (GVHD) in recipients conditioned with total body irradiation (TBI).

250 sphamide of 60 mg/kg per day for 2 days, and total body irradiation (TBI).

251 peutics Inc., in mice exposed to Co-60 gamma total body irradiation (TBI).

252 d donors received fludarabine and 200 cGy of total body irradiation (TBI); UCB recipients received cy

253 )) rats were conditioned with 600 to 300 cGy total body irradiation (TBI, day-1), and 100 x 10(6) T-c

254 Next, nine dogs received 4.5 Gy total-body irradiation (TBI) and unmodified marrow graft

255 Recipient dogs were given 2-Gy total-body irradiation (TBI) before and a short course o

256 ents, certain other leukemogenic agents, and total-body irradiation (TBI) cause chromosomal damage th

257 tion (SCT) for hematologic malignancies with total-body irradiation (TBI) conditioning regimens, and

258 ocoumarin (DAMTC) to mitigate RIII following total-body irradiation (TBI) in C57BL/6 mice and underly

259 Impact of total-body irradiation (TBI) in conditioning regimen on

260 to show that temporarily blocking p53 during total-body irradiation (TBI) not only ameliorates acute

261 ars of age, received either cyclophosphamide/total-body irradiation (TBI) or busulfan/cyclophosphamid

262 Cyclophosphamide (Cy) combined with total-body irradiation (TBI) or with busulfan (Bu) are c

263 no administered 24 h before or after 4 Gy of total-body irradiation (TBI) promoted rapid and complete

264 ne adults received cyclophosphamide (CY) and total-body irradiation (TBI) supported by autologous bon

265 er 2 (25 patients) or 12 Gy (25 patients) of total-body irradiation (TBI) was administered before cel

266 n diagnosis, type of transplantation, use of total-body irradiation (TBI), and presence of graft-vers

267 with age and after genotoxic stress, such as total-body irradiation (TBI).

268 ool and 100% survival after a lethal dose of total-body irradiation (TBI).

269 d: 4-6 of 6 matched dUCB-TCF (n = 120; TCF = total body irradiation [TBI] 200 cGy + cyclophosphamide

270 targeted forms of radiotherapy compared with total body irradiation that have the potential to decrea

271 ice deficient in both genes survive doses of total-body irradiation that lethally deplete hematopoiet

272 th severe thrombocytopenia induced by 6.5 Gy total body irradiation, thereby markedly abridging the d

273 eted PBSC grafts following conditioning with total body irradiation, thiotepa, and fludarabine.

274 ourteen Cynomolgus monkeys received low dose total body irradiation, thymic irradiation, antithymocyt

275 Increasing total body irradiation to 400 cGy substantially reduced

276 Furthermore, administering lethal doses of total body irradiation to GF mice produces markedly fewe

277 oned with fludarabine, cyclophosphamide, and total-body irradiation, underwent combined HCT/kidney tr

278 r synthesis is not detectable in response to total body irradiation unless NaCl is lowered by furosem

279 le protected rodents against lethal doses of total body irradiation up to 13 Gy, whether DIM dosing w

280 de 2 to 4 acute GVHD were cyclophosphamide + total-body irradiation versus busulfan + cyclophosphamid

281 nalysis of significant variables showed that total body irradiation was a risk factor for cataract fo

282 demia (RR = 3.2, P < .01); conditioning with total body irradiation was associated with an increased

283 A regimen of fludarabine and 200 cGy total body irradiation was followed by infusion of allog

284 Total body irradiation was given with each HSCT.

285 Total body irradiation was not required for immunologica

286 In addition, challenge of leukemic mice with total body irradiation was selectively toxic to normal h

287 Total-body irradiation was a major determinant for BCC.

288 Total-body irradiation was a significant risk factor for

289 ter they were exposed to increasing doses of total body irradiation, we additionally examined the rol

290 e marrow and to avoid the adverse effects of total body irradiation, we employed a murine parabiosis

291 itioned with T-cell depleting antibodies and total body irradiation with or without cyclophosphamide.

292 nrelated donors after conditioning with 2 Gy total body irradiation with or without fludarabine and p

293 Conditioning was with cyclophosphamide and total body irradiation with or without fludarabine.

294 ted with nonmyeloablative conditioning (2 Gy total-body irradiation with [n = 53] or without [n = 11]

295 = 28) donors after conditioning with 2 Gy of total-body irradiation with or without fludarabine.

296 = 85) grafts after conditioning with 2 Gy of total-body irradiation with or without fludarabine.

297 Rats were subjected to 15 Gy of total-body irradiation with x-rays.

298 courses of myeloablative therapy (including total-body irradiation) with PBSCR.

299 ose melphalan and autograft followed by 2-Gy total body irradiation, with or without fludarabine, and

300 e-unit transplantation in patients receiving total body irradiation without antithymocyte globulin (A